BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 14567764)

  • 61. Progestogen use in women approaching the menopause and breast cancer risk.
    Campagnoli C; Ambroggio S; Lotano MR; Peris C
    Maturitas; 2009 Apr; 62(4):338-42. PubMed ID: 19118958
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Oestrogens and progestins and breast cancer risk in post-menopausal women.
    La Vecchia C
    Pharmacol Res; 1995 Dec; 32(6):323-4. PubMed ID: 8736479
    [No Abstract]   [Full Text] [Related]  

  • 63. Breast cancer risk in postmenopausal women using estradiol-progestogen therapy.
    Lyytinen H; Pukkala E; Ylikorkala O
    Obstet Gynecol; 2009 Jan; 113(1):65-73. PubMed ID: 19104361
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Estrogen and combined estrogen-progestogen therapy in the menopause and breast cancer.
    La Vecchia C
    Breast; 2004 Dec; 13(6):515-8. PubMed ID: 15563861
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Hormone replacement therapy and the risk of breast cancer.
    Cuzick J
    Eur J Cancer; 2008 Nov; 44(16):2344-9. PubMed ID: 18783940
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Breast cancer and hormone-replacement therapy in the Million Women Study.
    Crosignani PG
    Maturitas; 2003 Oct; 46(2):91-2. PubMed ID: 14559371
    [No Abstract]   [Full Text] [Related]  

  • 67. [Hormone replacement therapy in patients after breast cancer].
    Köninger A; Kümmel S; Kimmig R
    MMW Fortschr Med; 2008 Oct; 150(43):32-4. PubMed ID: 19025144
    [No Abstract]   [Full Text] [Related]  

  • 68. Pros and cons. Hormone therapy can do wonders for women, but a new cancer study underscores the risks.
    Nash JM
    Time; 2000 Feb; 155(5):68-9. PubMed ID: 10787970
    [No Abstract]   [Full Text] [Related]  

  • 69. Postmenopausal hormone replacement therapy and risk of acute pancreatitis: a population-based case-control study.
    Tetsche MS; Jacobsen J; Nørgaard M; Baron JA; Sørensen HT
    Am J Gastroenterol; 2007 Feb; 102(2):275-8. PubMed ID: 17311649
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Re: Hormone therapy and the risk of breast cancer in BRCA1 mutation carriers.
    Eisinger F; Huiart L
    J Natl Cancer Inst; 2009 Feb; 101(4):277; author reply 277-8. PubMed ID: 19211447
    [No Abstract]   [Full Text] [Related]  

  • 71. The effect of estrogen plus progestin hormone therapy on breast cancer mortality: still unresolved.
    Schairer C; Brinton LA
    J Natl Cancer Inst; 2013 Apr; 105(8):513-4. PubMed ID: 23543780
    [No Abstract]   [Full Text] [Related]  

  • 72. Commentary: Hormone therapy and breast cancer incidence: did epidemiologists miss an effect on national trends?
    Paul C
    Int J Epidemiol; 2008 Jun; 37(3):638-40. PubMed ID: 18375444
    [No Abstract]   [Full Text] [Related]  

  • 73. [Postmenopausal hormone replacement under scrutiny. "Fatal therapy"?].
    Braendle W; Semler J
    MMW Fortschr Med; 2000 Aug; 142(33-34):11-2. PubMed ID: 10998894
    [No Abstract]   [Full Text] [Related]  

  • 74. Combined estrogen and testosterone use and risk of breast cancer in postmenopausal women.
    Tamimi RM; Hankinson SE; Chen WY; Rosner B; Colditz GA
    Arch Intern Med; 2006 Jul; 166(14):1483-9. PubMed ID: 16864758
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Practical guidelines for postmenopausal hormone therapy.
    Speroff L; Kenemans P; Burger HG
    Maturitas; 2005 May; 51(1):4-7. PubMed ID: 15883102
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Risk of breast cancer with progestins in combination with estrogen as hormone replacement therapy.
    Santen RJ; Pinkerton J; McCartney C; Petroni GR
    J Clin Endocrinol Metab; 2001 Jan; 86(1):16-23. PubMed ID: 11231971
    [No Abstract]   [Full Text] [Related]  

  • 77. Menopausal hormones and risk of ovarian cancer.
    Moorman PG; Schildkraut JM; Calingaert B; Halabi S; Berchuck A
    Am J Obstet Gynecol; 2005 Jul; 193(1):76-82. PubMed ID: 16021062
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Postmenopausal hormone therapy and the risk of breast cancer. A clinician's view.
    Speroff L
    Maturitas; 2004 Sep; 49(1):51-7. PubMed ID: 15351096
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Association between premenopausal progestogen use and postmenopausal hormonal therapy in the GAZEL cohort.
    Ringa V; Fritel X; Varnoux N; Zins M; Piault S; Quelen C
    Maturitas; 2007 Nov; 58(3):216-25. PubMed ID: 17919857
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Progesterone, progestins, pregnancy and breast cancer risk.
    Ferretti G
    Breast Cancer Res Treat; 2007 Jul; 103(3):373-4. PubMed ID: 17063269
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.